Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

OptiCept Technologies

2.80 SEK

-12.09 %

Less than 1K followers

OPTI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-12.09 %
-26.32 %
-44.22 %
-31.71 %
-43.55 %
-42.68 %
-78.09 %
-92.55 %
-44.47 %

OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.

Read more
Market cap
182.41M SEK
Turnover
1.18M SEK
Revenue
17.67M
EBIT %
-317.43 %
P/E
-
Dividend yield-%
-
Latest research

Latest analysis report

Released: 2024-12-02

Latest extensive report

Released: 2024-02-02

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
18/12
2025

Extraordinary general meeting '25

27/2
2026

Annual report '25

21/5
2026

General meeting '26

All
Research
Press releases
3rd party
ShowingAll content types
Regulatory press release12/1/2025, 2:30 PM

Kallelse till extra bolagsstämma i OptiCept Technologies AB (publ)

OptiCept Technologies
Regulatory press release12/1/2025, 2:30 PM

Notice of Extraordinary General Meeting in OptiCept Technologies AB (publ)

OptiCept Technologies
Regulatory press release11/26/2025, 5:15 PM

Rättelse: OptiCept Technologies Kvartalsrapport Q3 2025

OptiCept Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/26/2025, 5:15 PM

Correction: OptiCept Technologies Interim Report Q3 2025

OptiCept Technologies
Press release11/24/2025, 8:00 AM

Starkt kvartal och ny finansiering visar vägen till positivt EBITDA för helåret 2026.

OptiCept Technologies
Press release11/24/2025, 8:00 AM

Strong quarter and new financing show the path to positive EBITDA for the full year 2026

OptiCept Technologies
Press release11/24/2025, 6:58 AM

DNB Carnegie Access: OptiCept Technologies: Cash flow conversion concerning, raises debt – Q3 review

OptiCept Technologies
Regulatory press release11/23/2025, 7:55 PM

OptiCept refinansierar lån om cirka 21,4 MSEK och tillförs ytterligare likviditet genom nytt lån om cirka 17,5 MSEK samt upptar en kreditfacilitet om 10 MSEK

OptiCept Technologies
Regulatory press release11/23/2025, 7:55 PM

OptiCept refinances loan of approx. SEK 21.4 million, receives additional liquidity through a new loan of approx. SEK 17.5 million, and enters into a credit facility of SEK 10 million

OptiCept Technologies
Regulatory press release11/21/2025, 4:35 PM

OptiCept Technologies Kvartalsrapport Q3 2025

OptiCept Technologies
Regulatory press release11/21/2025, 4:35 PM

OptiCept Technologies Interim Report Q3 2025

OptiCept Technologies
Press release11/3/2025, 3:57 PM

DNB Carnegie Access: OptiCept Technologies: Deliveries on H1 order intake to commence – Q3 preview

OptiCept Technologies
Press release10/22/2025, 9:50 AM

OptiCept bygger regional säljorganisation

OptiCept Technologies
Regulatory press release10/21/2025, 8:35 AM

OptiCept Technologies AB tillkännager valberedning inför bolagsstämman 2026

OptiCept Technologies
Regulatory press release10/21/2025, 8:35 AM

OptiCept Technologies AB announces Nomination Committee ahead of the 2026 Annual General Meeting

OptiCept Technologies
Press release9/25/2025, 7:45 AM

OptiCept får ny order från juiceproducent i Costa Rica

OptiCept Technologies
Press release9/25/2025, 7:45 AM

OptiCept Receives New Order from Juice Producer in Costa Rica

OptiCept Technologies
Press release9/24/2025, 6:50 AM

OptiCept sänker sina produktionskostnader med 40%

OptiCept Technologies
Press release9/24/2025, 6:50 AM

OptiCept reduces its production costs by 40%

OptiCept Technologies
Press release9/19/2025, 6:30 AM

Ledande Citrusjuiceproducent utvärderar OptiCepts PEF-teknologi

OptiCept Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.